Best Ocular oncology surgery Doctors Worldwide — TOP 24

Associate Professor Muhammet Derda Ozer specializes in ocular oncology with advanced training at Wills Eye Institute, a global leader in eye care.

• Completed a prestigious ICO-STAAR Surgical Fellowship in Vitreo-Retina at the University of Kansas
• Published multiple research papers on ocular tumors and treatment outcomes
• Active member of the Turkish Ophthalmological Association
• Holds multiple International Council of Ophthalmology certifications

Head of the Orbital and Oculoplastics Department at Teknon Medical Center – accredited for orbital tumor surveillance and decompression surgery.

• 29 years of experience specializing in ocular oncology and oculoplastics
• Expert in orbital surgery and lacrimal duct procedures
• Published 2 original articles and co-authored 3 ophthalmology books
• Member of Spanish Society of Ocular and Orbital Plastic Surgery

Dr. Jindarak brings specialized training from Chicago's Illinois Eye and Ear Infirmary to Intrarat Hospital's ocular oncology team.

• Certified ophthalmologist from Chulalongkorn University
• Fellowship-trained in glaucoma at a top US institution
• Focuses specifically on eye-related cancers and vision conditions
• MD with full medical training beyond optometry

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Op. Dr. Yalçın İşcan is an ophthalmologist. He graduated from Istanbul University in 2005. He completed his ophthalmology residency at Bakırköy Dr. Sadi Konuk Training and Research Hospital in 2010. He has more than 15 years of specialist experience. He performed thousands of eye surgeries at Batman Regional Hospital between 2011 and 2015. He worked at Private Batman Dünya Hospital from 2015 to 2025.

At Dünya Hospital, he provided care in cataract surgery, corneal transplantation, refractive procedures (PRK, LASIK, SMILE, phakic IOL), strabismus, oculoplastics, lacrimal surgery, pterygium, and keratoconus treatments (CXL, ICRS). He helped develop the unit into a regional referral center. Since 2023, he has also practiced two days a week at Pendik Medical Park and Kudret Göz Istanbul. Since 2020, he has been active in R&D. He founded a technopark start-up and built an AI-based red-eye decision support system. He continues to develop ophthalmic software and devices. He has several publications.

Specializes in corneal and refractive surgery with a subspecialty in ocular oncology – offering precise, targeted treatments at Intrarat Hospital.

• Graduated from Phramongkutklao College of Medicine
• Certified in Ophthalmology at Phramongkutklao Hospital
• Fellowship in Corneal and Refractive Surgery at Khonkaen University

Prof. Celebi specializes in ocular oncology surgery at İstinye University Liv Hospital, with a Harvard fellowship in glaucoma and extensive orbital surgery expertise.

• Trained at Harvard's Massachusetts Eye & Ear Infirmary
• Performs complex orbital procedures like enucleation
• Executive board member of TOD's Cornea Unit
• Published 58 international articles on ophthalmology
• Multiple academic achievement awards from Acıbadem University

Dr. Alemdar specializes in ocular oncology surgery at Medical Park Antalya Hospital Complex, bringing extensive training and experience in medical oncology.

• Completed medical oncology specialization at Akdeniz University
• Over 20 years of experience of experience in internal medicine and oncology
• Worked at prestigious institutions including Akdeniz University Hospital

Dr. Bujar Rizvanolli focuses on laser-assisted corneal procedures at Italian Eye Hospital, known for precision treatments like cross-linking.

• Specializes in keratoconus treatment and refractive surgery
• Performs TransPRK and other touchless laser procedures
• Trained at University Clinical Center of Sarajevo
• Patient-centered approach reduces anxiety and improves recovery

Prof Yusuf Yildirim specializes in ocular oncology surgery at Medipol Acibadem District Hospital, bringing extensive expertise in corneal and ocular surface diseases.

• Holds European Board of Ophthalmology Diploma (EBOD)
• Associate Professor at University of Health Sciences
• Active member of Turkish Ophthalmology Society
• Specializes in keratoplasty and refractive surgery

Specializes in vitreo-retinal surgery and medical retina – Dr. Yayla brings expertise in complex ocular oncology cases at Medipol University Pendik Hospital.

• Fellowship-trained at Gazi University in vitreo-retinal surgery
• Additional training in retinopathy of prematurity
• 11 years of experience of experience at Kocaeli Derince Training and Research Hospital
• Current position at a leading university hospital